48,436
edits
Difference between revisions of "Adenomatoid tumour"
Jump to navigation
Jump to search
more
(split-out) |
(more) |
||
| Line 1: | Line 1: | ||
{{ Infobox diagnosis | |||
| Name = {{PAGENAME}} | |||
| Image = Adenomatoid_tumour_-b-_very_high_mag.jpg | |||
| Width = | |||
| Caption = Adenomatoid tumour. [[H&E stain]]. | |||
| Micro = small tubulocystic spaces lined by unremarkable mesothelium; the pseudotubular spaces are crossed by "thread-like bridging strands, usu. well-circumscribed | |||
| Subtypes = | |||
| LMDDx = [[lymphangioma]], [[leiomyoma]], [[vascular tumours]] | |||
| Stains = | |||
| IHC = calretinin +ve, AE1/AE3 +ve, CD31 -ve | |||
| EM = | |||
| Molecular = | |||
| IF = | |||
| Gross = | |||
| Grossing = | |||
| Site = [[uterus]], adnexa ([[fallopian tube]]/[[ovaries]]) | |||
| Assdx = | |||
| Syndromes = | |||
| Clinicalhx = | |||
| Signs = | |||
| Symptoms = | |||
| Prevalence = uncommon | |||
| Bloodwork = | |||
| Rads = | |||
| Endoscopy = | |||
| Prognosis = benign | |||
| Other = | |||
| ClinDDx = [[leiomyoma]], other adenxal masses | |||
}} | |||
'''Adenomatoid tumour''' is a rare benign tumour derived from the [[mesothelium]]. | '''Adenomatoid tumour''' is a rare benign tumour derived from the [[mesothelium]]. | ||
| Line 18: | Line 47: | ||
*[[Lymphangioma]]. | *[[Lymphangioma]]. | ||
*[[Leiomyoma]]. | *[[Leiomyoma]]. | ||
*[[Vascular tumours]]. | |||
===Images=== | ===Images=== | ||
| Line 32: | Line 62: | ||
*Calretinin +ve. | *Calretinin +ve. | ||
*AE1/AE3 +ve. | *AE1/AE3 +ve. | ||
*CK7 +ve.<ref name=pmid22553816>{{Cite journal | last1 = Terada | first1 = T. | title = An immunohistochemical study of adenomatoid tumors of the uterus and fallopian tube. | journal = Appl Immunohistochem Mol Morphol | volume = 20 | issue = 2 | pages = 173-6 | month = Mar | year = 2012 | doi = | PMID = 22553816 }}</ref> | |||
Others:<ref name=pmid22553816/> | |||
*CK20 -ve. | |||
*EMA -ve. | |||
*HMB-45 -ve. | |||
*Vimentin -ve. | |||
*Desmin -ve. | |||
*CD31 -ve. | *CD31 -ve. | ||
* | *CD34 -ve. | ||
==See also== | ==See also== | ||